Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged 3A Capital Advisors

Why Rakesh Jhunjhunwala’s Fav Gaming Stock Is A Great Buy Now: Kalpraj Dharamshi (Applying Howard Marks’ Theory)



Rakesh Jhunjhunwala’s all-time favourite gaming stock is in the doldrums. Kalpraj Dharamshi, the veteran value investor, has made out a strong case on why the stock is a great buy at the present valuations. His analysis appears to be in tune with the theory propounded by Howard Marks, the great investment guru

Rakesh Jhunjhunwala Thrills Niraj Dalal By Endorsing His Stock Pick



Niraj Dalal’s brilliant analysis appears to have struck a chord with Rakesh Jhunjhunwala and he has rushed to grab a chunk of the stock. Will Niraj Dalal’s prognosis bear fruit and the stock deliver bumper gains?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!